Pharmaceutical Preparations · DE · CIK 1070081
Develops and commercializes therapeutics for rare diseases and challenging conditions
Comparable business profile · signals at a glance
In the 90 days to Mar 12, 2026: 10 sold $14.8M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 12, 2026 | Klein Matthew B.CHIEF EXECUTIVE OFFICER | Sell | 2,662 | $64.08 | $171K |
| Mar 10, 2026 | Okey StephanieDirector | Sell | 14,000 | $70.00 | $980K |
| Mar 10, 2026 | Okey StephanieDirector | Sell | 1,167 | $70.00 | $82K |
| Mar 5, 2026 | Golden Lee ScottEVP & CHIEF MEDICAL OFFICER | Sell | 10,000 | $63.38 | $634K |
| Mar 5, 2026 | Okey StephanieDirector | Sell | 6,333 | $63.38 | $401K |
| Mar 5, 2026 | Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER | Sell | 3,989 | $63.38 | $253K |
| Feb 19, 2026 | Boulding Mark ElliottEXEC. VP AND CLO | Sell | 1,629 | $69.82 | $114K |
| Feb 19, 2026 | Boulding Mark ElliottEXEC. VP AND CLO | Sell | 590 | $69.82 | $41K |
| Feb 19, 2026 | Boulding Mark ElliottEXEC. VP AND CLO | Sell | 588 | $68.54 | $40K |
| Feb 19, 2026 | Boulding Mark ElliottEXEC. VP AND CLO | Sell | 212 | $68.54 | $15K |
| Feb 18, 2026 | Klein Matthew B.CHIEF EXECUTIVE OFFICER | Sell | 7,371 | $69.36 | $511K |
| Feb 18, 2026 | Boulding Mark ElliottEXEC. VP AND CLO | Sell | 3,081 | $69.36 | $214K |
| Feb 18, 2026 | Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER | Sell | 3,056 | $69.36 | $212K |
| Feb 18, 2026 | Pauwels EricCHIEF BUSINESS OFFICER | Sell | 3,019 | $69.36 | $209K |
| Feb 18, 2026 | Gravier PierreCHIEF FINANCIAL OFFICER | Sell | 2,992 | $69.36 | $208K |
| Feb 18, 2026 | Utter Christine MarieSVP, CHIEF ACCOUNTING OFFICER | Sell | 2,494 | $69.36 | $173K |
| Feb 18, 2026 | Golden Lee ScottEVP & CHIEF MEDICAL OFFICER | Sell | 2,484 | $69.36 | $172K |
| Feb 18, 2026 | Almstead Neil GregoryCHIEF TECHNICAL OPS OFFICER | Sell | 65 | $69.36 | $5K |
| Feb 17, 2026 | Boulding Mark ElliottEXEC. VP AND CLO | Sell | 2,811 | $69.29 | $195K |
| Feb 17, 2026 | Boulding Mark ElliottEXEC. VP AND CLO | Sell | 2 | $70.13 | $140 |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.